Preclinical studies have shown that propofol may exacerbate Aβ aggregation, induce tau hyperphosphorylation, and trigger neuronal apoptosis, particularly in models predisposed to AD pathology [21,26,27,28]. Here, MAPT is linked to Alzheimer disease.